tiprankstipranks
Trending News
More News >
Smith & Nephew Snats (SNN)
NYSE:SNN
US Market

Smith & Nephew Snats (SNN) Earnings Dates, Call Summary & Reports

Compare
198 Followers

Earnings Data

Report Date
Jul 30, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.99
Last Year’s EPS
0.86
Same Quarter Last Year
Based on 2 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Mar 02, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong execution and momentum: double-digit improvement in key profitability and cash metrics for FY2025 (margin expansion, $840M free cash flow, adjusted EPS +21%), broad-based revenue growth across business units, record adoption of CORI robotics, and clear cost-savings progress. Management provided constructive FY2026 guidance (~6% organic revenue growth, ~8% trading profit growth) and a disciplined capital allocation approach including targeted M&A (Integrity) aligned with strategy. Offsetting these positives are significant, but largely manageable, near-term headwinds: China VBP effects (now smaller on top line but still weighing on profit), CMS skin-substitute reimbursement changes (material near-term pressure on that subcategory), tariff and reimbursement impacts, and a one-off $159M portfolio rationalization charge. Overall the positives (growth, margin expansion, cash generation, innovation pipeline and cost savings) materially outweigh the near-term challenges and one-off charges, with a credible plan to offset headwinds and deliver further improvement over the medium term.
Company Guidance
Smith & Nephew guided 2026 to around 6% organic revenue growth and roughly 8% organic trading profit growth (with trading profit expected to grow ahead of revenue), and advised total trading profit of about $1.3 billion including the Integrity Orthopaedics acquisition (marginally dilutive in 2026, broadly neutral in 2027 and accretive in 2028). Management expects free cash flow of ~ $800 million in 2026, group ROIC >10% excluding Integrity, and finished 2025 with leverage of ~1.7x adjusted net debt/EBITDA (buybacks to be considered subject to a ~2x target), while maintaining a dividend payout ratio of 35–40%. Guidance is phased to a stronger second half (H1 revenue growth ~4.5–5% and H2 ~7.5–8%; profit growth H1 ~5.5–6% and H2 ~9–10%), factors in one fewer trading day in Q1 and one extra in Q4, and assumes headwinds of c.$60m from tariffs (vs $17m in 2025) and $20–40m incremental impact from wound reimbursement that management expects to more than offset via ~ $150m of savings in 2026 plus revenue leverage. The company also reiterated its mid‑term RISE ambitions of 6–7% organic revenue CAGR, 9–10% trading profit CAGR, >$1bn free cash flow in 2028 and 12–13% ROIC by 2028.
Full-Year Revenue Growth
FY2025 revenue of $6.2B, up 5.3% underlying (6.1% reported), ahead of guidance; 2022–2025 revenue CAGR of 5.7%.
Strong Q4 Performance
Q4 revenue of $1.7B, up 6.2% underlying and 8.3% reported (210 bps FX tailwind); average daily sales growth of 4.5% and broad-based regional growth (U.S. +5.6%, other established +7.2%, emerging +6.4%).
Margin Expansion and Trading Profit
Trading profit rose to $1.2B for the year (+$162M year-on-year) and trading margin expanded 160 basis points to 19.7% in FY2025 (gross margin 70.9%, +60 bps).
Cash Generation and Returns
Free cash flow of $840M, up 52.5% year-on-year and well ahead of initial guidance (> $600M); net debt $2.76B with leverage ~1.7x adjusted net debt/EBITDA; ROIC improved to 8.3% (9.9% excluding portfolio rationalization).
Operational Progress and Cost Savings
Cumulative efficiency savings of $280M achieved to end-2025 against a $325–375M by-2027 target; 160 bps FY25 margin expansion driven by enterprise-wide cost savings, manufacturing optimization, productivity and portfolio rationalization; group days sales inventory reduced materially (group DSI down 21 days excl. rationalization, 51 days incl.).
Innovation-led Growth
Over 60% of 2025 growth came from products launched in the last five years; 44 product launches over the last 3 years and guidance to launch 16 products in 2026; record CORI placements globally with 45% of CORI placements in ASCs and CORI-associated accounts showing Knee growth ~850 bps higher.
Portfolio and Capital Actions
Completed $500M share buyback in H2 2025; adjusted EPS grew 21% to $1.02 (benefitting from buyback); full-year dividend proposed +4.3% to $0.391; announced acquisition of Integrity Orthopaedics (up to $450M) to strengthen shoulder/rotator cuff franchise.

Smith & Nephew Snats (SNN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SNN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2026
2026 (Q2)
0.99 / -
0.858
Mar 02, 2026
2025 (Q4)
1.16 / 1.18
0.93825.80% (+0.24)
Aug 05, 2025
2025 (Q2)
0.79 / 0.86
0.75613.49% (+0.10)
Feb 25, 2025
2024 (Q4)
0.92 / 0.94
0.958-2.09% (-0.02)
Aug 01, 2024
2024 (Q2)
0.79 / 0.76
0.78.00% (+0.06)
Feb 27, 2024
2023 (Q4)
0.97 / 0.96
0.8710.11% (+0.09)
Aug 03, 2023
2023 (Q2)
0.73 / 0.70
0.762-8.14% (-0.06)
Feb 21, 2023
2022 (Q4)
0.73 / 0.87
0.88.75% (+0.07)
Jul 28, 2022
2022 (Q2)
0.76 / 0.76
0.776-1.80% (-0.01)
Feb 22, 2022
2021 (Q4)
0.87 / 0.80
1.026-22.03% (-0.23)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SNN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 02, 2026
$36.90$35.76-3.09%
Aug 05, 2025
$30.55$35.20+15.23%
Feb 25, 2025
$25.66$27.45+6.96%
Aug 01, 2024
$27.85$29.77+6.88%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Smith & Nephew Snats (SNN) report earnings?
Smith & Nephew Snats (SNN) is schdueled to report earning on Jul 30, 2026, Before Open (Confirmed).
    What is Smith & Nephew Snats (SNN) earnings time?
    Smith & Nephew Snats (SNN) earnings time is at Jul 30, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SNN EPS forecast?
          SNN EPS forecast for the fiscal quarter 2026 (Q2) is 0.99.